Series date: 
01/01/2023 - 7:00am to 12/31/2023 - 8:00am

TARGET AUDIENCE
Physicians that work within the transplant department and cardiology, as well as fellows, nurses, and NPs who work with heart transplant patients.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Recognize current medical therapies and outcomes in patients with advanced heart failure
  • Maintain up-to-date information on changing pharmacological interventions in patients with advanced CHF
  • Maintain up-to-date information on changing technologies in available and experimental devices for mechanical circulatory support
  • Manage patients following implantation of left ventricular assist devices
  • Describe current medical therapies both available and experimental for immune suppression following heart transplantation
  • Manage patients following heart transplantation and anticipating complications

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
 
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
 
Listed below are individuals with control of the content of this program who have disclosed…
 
Relevant financial relationship(s) with ineligible companies:
None

All relevant financial relationships have been mitigated. 
 
No relevant financial relationship(s) with ineligible companies:
Juan Carlos Leoni Moreno, MD; Pamela Fields, ARNP; Karen Mayes, PA-C; Jan Martin
 

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 
 
CE Broker Code: 21R00837-C
 
ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
 
COURSE DIRECTOR
Juan Carlos Leoni Moreno, MD
 
QUESTIONS?
Contact Jan Martin, Department Coordinator at 3-2473
Support location: 
Florida

Sessions

Session Date
Advanced Heart Failure/Transplant Conference, "Cardiac Sarcoidosis, 01/10/2023" VIRTUAL 01/10/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "Pacemakers and ICD Troubleshooting, 01/17/2023" VIRTUAL 01/17/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "Cardiopulmonary Stress Testing 01/24/2023" VIRTUAL 01/24/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "Don't Forget About Me: Evaluation and Management of Right Sided Heart Failure, 01/31/2023" VIRTUAL 01/31/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "Tricuspid Valve Interventions - From Interventional Cardiology Perspective - 02/07/2023" VIRTUAL 02/07/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "Myocardial Inflammation after ACS and Development of Heart Failure, 02/14/2023" VIRTUAL 02/14/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference, "How Do I Select Heart Failure Patients to Refer to EP for Ablation, 02/21/2023" VIRTUAL 02/21/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference "Journal Club 02/28/2023" VIRTUAL 02/28/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference: "Amyloidosis 101 - 03/07/2023" VIRTUAL 03/07/2023 - 7:00am to 8:00am
Advanced Heart Failure/Transplant Conference: "Right Ventricular Performance, Critical Components, Management and Evolving Role PAPi - 03/14/2023" VIRTUAL 03/14/2023 - 7:00am to 8:00am

Pages